Opinion Poultry Production
Releasing vaccines faster
- Author: Wiebe van der Sluis
- Post a comment
Comments ( 9 )
I'm of the opinion that truly much of the spread of deadly viral diseases[including HPAI] is through movement of animal products and therefore more of the emphasis should be more on resricting the mobility of these products from an affected region[s] than to the already developed preventive measures[vaccines]
Amenya Hesbon[Univ of Nairobi BVM student] // Monday 01 October 2007
Discussing vaccine registration is a bit ahead of the game. First you need to discuss the desirability of vaccination, then the type (heterologous, homologous, autogenous etc), then trade issues if vaccination is used and only when all that is sorted out does it make sense to speed up registration procedures. As AI is a notifiable disease vaccination merely delays the inevitable culling since it can, at best, reduce susceptibilty to infection, not prevent it. Studies have shown field immunity to not be much more than 70%. Is that good enough?
Kevin Lovell, Southern African Poultry Association // Monday 01 October 2007
This is a debatable and hot issue ever , no question speeding up the vaccine development will be of paramount importance but it should be speeding up in a slow way pre-conditioned with enough field analytical data .I am afraid the market contests and the feeling of being number one in the market share will adversely exploite the sincere call for faster vaccine release !!!
the majority spready of the AI could be linked with the products, in a country like Afghanistan where no poultry industry developed the cases mostly linked in the areas where live birds crossed from neighbouring countries, but the processed meat is frozen i dont know how the resistant of the virus against this frozen meat, and what about feed thanks. Samsor
Dr. Abdul Qader Samsor,Livestock advisor / ASAP / UAID // Sunday 30 September 2007
Being associated with an avian Biological Company, I second the opinion of the author. There ought to be a stadard affirmation from the nations on such global maladies like AI. The geo-political scenario must NOT be a limiting factor in the swift and accessible reach of the remedial efforts being done by the scientists and researchers.Besides this logistics and regulatory limitations, there must be an international policy devised to synchronise the R & D activities and information from the EU, for example, with the regions like South East Asia etc. Still a lot more work, a lot more R & D is required for certain Avian Diseases and specially for AI, in some parts of the world, where the challenge of HPAI is very high! Regards, Dr.Asif From Ceva-EVP Pakistan.
The article contains a very good opinion/practise in a situation whereby there are sincere operators.In nigaria,there have been some cases of drugs/vaccines destrucution by the regulatory authority due to non conformity with standard yet these products are release for export from the producers' country.I would rather appeal to all concern in the production of these products to be more honest and be accurate to avoid continuous laboratory analysis before being release to market for farmers' uses.



Index

